Patrick Pauwels

15.0k total citations · 1 hit paper
305 papers, 10.6k citations indexed

About

Patrick Pauwels is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Patrick Pauwels has authored 305 papers receiving a total of 10.6k indexed citations (citations by other indexed papers that have themselves been cited), including 151 papers in Oncology, 111 papers in Molecular Biology and 110 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Patrick Pauwels's work include Lung Cancer Treatments and Mutations (57 papers), Cancer Genomics and Diagnostics (53 papers) and Cancer Immunotherapy and Biomarkers (32 papers). Patrick Pauwels is often cited by papers focused on Lung Cancer Treatments and Mutations (57 papers), Cancer Genomics and Diagnostics (53 papers) and Cancer Immunotherapy and Biomarkers (32 papers). Patrick Pauwels collaborates with scholars based in Belgium, Netherlands and United States. Patrick Pauwels's co-authors include Filip Lardon, Marc Peeters, Christian Rolfo, Karen Zwaenepoel, Vanessa Deschoolmeester, Evelien Smits, Olivier De Wever, Julie Jacobs, An Wouters and Raf Sciot and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Patrick Pauwels

300 papers receiving 10.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The potential and controversy of targeting STAT family members in cancer

2019 273 citations Julie Jacobs, Christophe Deben et al. profile →

Peers

Countries citing papers authored by Patrick Pauwels

Since Specialization

Citations

This map shows the geographic impact of Patrick Pauwels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Pauwels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Pauwels more than expected).

Fields of papers citing papers by Patrick Pauwels

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Pauwels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Pauwels. The network helps show where Patrick Pauwels may publish in the future.

Co-authorship network of co-authors of Patrick Pauwels

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Pauwels. A scholar is included among the top collaborators of Patrick Pauwels based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Pauwels. Patrick Pauwels is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	NPY Methylated ctDNA is a Promising Biomarker for Treatment Response Monitoring in Metastatic Colorectal Cancer 2023 ·Clinical Cancer Research ·(unknown), Greetje Vanhoutte, Willem Lybaert, Wim Demey, Jochen Decaestecker, (unknown), (unknown), Karen Zwaenepoel, Patrick Pauwels, Erik Fransén, Ken Op de Beeck, Guy Van Camp, Christian Rolfo, Marc Peeters	12
2	Urine biomarkers in cancer detection: A systematic review of preanalytical parameters and applied methods 2023 ·International Journal of Cancer ·(unknown), Karen Zwaenepoel, Wiebren Tjalma, Christophe Deben, Koen Beyers, Vanessa Vankerckhoven, Patrick Pauwels, Alex Vorsters	34
3	Protein Biomarker Discovery Studies on Urinary sEV Fractions Separated with UF-SEC for the First Diagnosis and Detection of Recurrence in Bladder Cancer Patients 2023 ·Biomolecules ·(unknown), (unknown), Hanny Willems, Filip Ameye, Stefan De Wachter, Patrick Pauwels, Inge Mertens	7
4	Recent Advances of Immune Checkpoint Inhibition and Potential for (Combined) TIGIT Blockade as a New Strategy for Malignant Pleural Mesothelioma 2022 ·Biomedicines ·(unknown), Annelies Janssens, Jo Raskin, Patrick Pauwels, Jan P. van Meerbeeck, Evelien Smits, Elly Marcq	5
5	Prognostic and Predictive Biomarkers in Non-Small Cell Lung Cancer Patients on Immunotherapy—The Role of Liquid Biopsy in Unraveling the Puzzle 2021 ·Cancers ·(unknown), Karen Zwaenepoel, Vasiliki Siozopoulou, Jo Raskin, (unknown), Geert Baggerman, Laure Sorber, Geert Roeyen, Marc Peeters, Patrick Pauwels	21
6	Implementation of MALDI Mass Spectrometry Imaging in Cancer Proteomics Research: Applications and Challenges 2020 ·Journal of Personalized Medicine ·(unknown), Kurt Boonen, Evelyne Maes, Inge Mertens, Patrick Pauwels, Geert Baggerman	19
7	Staining Performance of ALK and ROS1 Immunohistochemistry and Influence on Interpretation in Non–Small-Cell Lung Cancer 2020 ·Journal of Molecular Diagnostics ·Cleo Keppens, Jan H. von der Thüsen, Patrick Pauwels, Aleš Ryška, (unknown), Ed Schuuring, Keith Miller, Erik Thunnissen, Karen Zwaenepoel, Elisabeth Dequeker	7
8	Mass Spectrometry Imaging Reveals Neutrophil Defensins as Additional Biomarkers for Anti-PD-(L)1 Immunotherapy Response in NSCLC Patients 2020 ·Cancers ·(unknown), Julie Jacobs, Christophe Deben, Christophe Hermans, Glenn Broeckx, Evelien Smits, Evelyne Maes, Jo Raskin, Patrick Pauwels, Geert Baggerman	19
9	Overcoming Intrinsic and Acquired Cetuximab Resistance in RAS Wild-Type Colorectal Cancer: An In Vitro Study on the Expression of HER Receptors and the Potential of Afatinib 2019 ·Cancers ·Ines De Pauw, Filip Lardon, Jolien Van den Bossche, (unknown), Patrick Pauwels, Marc Peeters, Jan B. Vermorken, An Wouters	14
10	Circulating Cell-Free DNA and RNA Analysis as Liquid Biopsy: Optimal Centrifugation Protocol 2019 ·Cancers ·Laure Sorber, Karen Zwaenepoel, Julie Jacobs, Koen De Winne, Sofie Goethals, Pablo Reclusa, (unknown), (unknown), Filip Lardon, Geert Roeyen, Marc Peeters, Jan P. van Meerbeeck, Christian Rolfo, Patrick Pauwels	74
11	MALDI Mass Spectrometry Imaging Linked with Top-Down Proteomics as a Tool to Study the Non-Small-Cell Lung Cancer Tumor Microenvironment 2019 ·Methods and Protocols ·(unknown), Geert Van Raemdonck, (unknown), Hanny Willems, Kurt Boonen, Evelyne Maes, Inge Mertens, Patrick Pauwels, Geert Baggerman	19
12	PD-L1 testing for non-small cell lung cancer : Belgian guidelines 2018 ·Ghent University Academic Bibliography (Ghent University) ·Patrick Pauwels, Myriam Remmelink, Delphine Hoton, Jo Van Dorpe, Karl Dhaene, (unknown), Anne Jouret‐Mourin, Birgit Weynand, Nicky D’Haene	1
13	Describing the Reportable Range Is Important for Reliable Treatment Decisions 2018 ·Journal of Molecular Diagnostics ·(unknown), Lien Spans, Ed Schuuring, Cleo Keppens, Karen Zwaenepoel, Patrick Pauwels, Jeroen Van Houdt, Elisabeth Dequeker	9
14	Ultrafiltration and size exclusion chromatography combined with asymmetrical‐flow field‐flow fractionation for the isolation and characterisation of extracellular vesicles from urine 2018 ·Journal of Extracellular Vesicles ·(unknown), (unknown), Geert Baggerman, Hanny Willems, Kurt Boonen, Christian Rolfo, Patrick Pauwels, An Jacobs, (unknown), William C. Cho, Inge Mertens	126
15	Radiotherapy-Activated Cancer-Associated Fibroblasts Promote Tumor Progression through Paracrine IGF1R Activation 2017 ·Cancer Research ·Joke Tommelein, Elly De Vlieghere, Laurine Verset, (unknown), Justine Leenders, Benedicte Descamps, Annelies Debucquoy, Christian Vanhove, Patrick Pauwels, Christian Gespach, Anne Vral, Astrid De Boeck, Karin Haustermans, Pascal De Tullio, Wim Ceelen, Pieter Demetter, Tom Boterberg, Marc Bracke, Olivier De Wever	128
16	Multidisciplinary molecular tumour board : a tool to improve clinical practice and selection accrual for clinical trials in cancer patients 2016 ·Ghent University Academic Bibliography (Ghent University) ·Christian Rolfo, (unknown), Pieter‐Jan van Dam, Amélie Dendooven, Christine Weyn, Marika Rasschaert, Lorne Houten, (unknown), Jan P. van Meerbeeck, Patrick Pauwels, Marc Peeters	1
17	Pathological diagnosis and molecular testing in non-small cell lung cancer: Belgian guidelines 2016 ·Ghent University Academic Bibliography (Ghent University) ·Patrick Pauwels, Myriam Remmelink, Delphine Hoton, Jo Van Dorpe, Karl Dhaene, (unknown), Anne Jouret‐Mourin, Birgit Weynand, Nicky D’Haene	4
18	Detection of MDM2/CDK4 amplification in lipomatous soft tissue tumors from formalin-fixed, paraffin-embedded tissue: comparison of multiplex ligation-dependent probe amplification (MLPA) and fluorescence in situ hybridization (FISH) 2011 ·Ghent University Academic Bibliography (Ghent University) ·David Creytens, (unknown), (unknown), Joost van Gorp, Patrick Pauwels	2
19	Expression of hexokinase II in pancreatic cancer predicts survival 2008 ·Ghent University Academic Bibliography (Ghent University) ·(unknown), Philippe Fonteyne, Nancy Van Damme, Patrick Pauwels, Bernard de Hemptinne, Christophe Van de Wiele, Marc Peeters	4
20	Urinary bladder inflammatory myofibroblastic tumor with ALK-ATIC fusion 2003 ·Ghent University Academic Bibliography (Ghent University) ·David Creytens, Maria Dêbiec‐Rychter, Patrick Pauwels	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact